# B3GAT1

## Overview
The B3GAT1 gene encodes the enzyme beta-1,3-glucuronyltransferase 1, which is a glycosyltransferase involved in the biosynthesis of glycosaminoglycans and the human natural killer 1 (HNK-1) glycan. This enzyme is crucial for the formation of glycan structures that are integral to the extracellular matrix and cell surface molecules, influencing processes such as cell signaling, adhesion, and migration (Trimarco2022Cellular; Huffman2011Polymorphisms). Beta-1,3-glucuronyltransferase 1 operates within the Golgi apparatus, where it facilitates the transfer of glucuronic acid to glycoproteins, thereby playing a significant role in cellular communication and tissue development (Huffman2011Polymorphisms). The enzyme's activity is also linked to neural functions, particularly in learning and memory, through its involvement in the biosynthesis of the HNK-1 glycan (Hashimoto2020Regionspecific). Additionally, B3GAT1 has been implicated in immune responses and antiviral defense mechanisms, highlighting its potential clinical significance (Trimarco2022Cellular).

## Function
The B3GAT1 gene encodes the enzyme beta-1,3-glucuronyltransferase 1, which plays a crucial role in the biosynthesis of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. These molecules are essential components of the extracellular matrix and cell surface molecules, contributing to cell signaling, adhesion, and migration (Huffman2011Polymorphisms). The enzyme is active in the Golgi apparatus, where it catalyzes the transfer of glucuronic acid to glycoproteins, influencing cellular communication and tissue development (Huffman2011Polymorphisms).

B3GAT1 is also involved in the biosynthesis of the human natural killer 1 (HNK-1) glycan, a carbohydrate epitope expressed on a subset of human lymphocytes, including natural killer cells. This process involves the addition of glucuronic acid to the terminal N-acetyllactosamine disaccharide, forming the HNK-1 epitope precursor (Trimarco2022Cellular; Huffman2011Polymorphisms). The HNK-1 glycan is significant in neural functions, particularly in the brain, where it is involved in learning and memory (Hashimoto2020Regionspecific).

In the context of viral infections, B3GAT1 modifies cell surface glycans, reducing sialic acid expression, which is a key receptor for viruses like influenza. This modification restricts viral entry, highlighting B3GAT1's potential role in antiviral defense (Trimarco2022Cellular).

## Clinical Significance
B3GAT1, also known as beta-1,3-glucuronyltransferase 1, has been implicated in various clinical conditions due to alterations in its expression levels. In the context of viral infections, B3GAT1 overexpression has been shown to restrict influenza virus infection by modifying cell surface glycans, thereby preventing viral entry. This suggests its potential as a target for antiviral therapies, although the clinical application of this strategy requires further investigation to address challenges such as the method of B3GAT1 induction and potential immune responses (Trimarco2022Cellular).

In allergic conditions, particularly insect venom allergy (IVA) in patients with mastocytosis, B3GAT1 expression is significantly lower in those experiencing anaphylaxis. This underexpression may be linked to immune response alterations, indicating a potential role in immune dysfunction and allergic reactions (Górska2016The).

Additionally, genetic studies have identified polymorphisms in B3GAT1 associated with variations in glycosylation traits, which could influence immune function and disease susceptibility. However, the specific clinical significance of these polymorphisms in diseases remains to be fully elucidated (Huffman2011Polymorphisms). Overall, B3GAT1's role in disease is complex and involves its function in glycan biosynthesis and immune regulation.


## References


[1. (Hashimoto2020Regionspecific) Misuzu Hashimoto, Tetsuya Hirata, Chizuko Yonekawa, Kaho Takeichi, Akiyoshi Fukamizu, Tsutomu Nakagawa, and Yasuhiko Kizuka. Region-specific upregulation of hnk-1 glycan in the prmt1-deficient brain. Biochimica et Biophysica Acta (BBA) - General Subjects, 1864(3):129509, March 2020. URL: http://dx.doi.org/10.1016/j.bbagen.2019.129509, doi:10.1016/j.bbagen.2019.129509. This article has 6 citations.](https://doi.org/10.1016/j.bbagen.2019.129509)

[2. (Trimarco2022Cellular) Joseph D. Trimarco, Sarah L. Nelson, Ryan R. Chaparian, Alexandra I. Wells, Nathan B. Murray, Parastoo Azadi, Carolyn B. Coyne, and Nicholas S. Heaton. Cellular glycan modification by b3gat1 broadly restricts influenza virus infection. Nature Communications, October 2022. URL: http://dx.doi.org/10.1038/s41467-022-34111-0, doi:10.1038/s41467-022-34111-0. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-34111-0)

[3. (Huffman2011Polymorphisms) Jennifer E. Huffman, Ana Knežević, Veronique Vitart, Jayesh Kattla, Barbara Adamczyk, Mislav Novokmet, Wilmar Igl, Maja Pučić, Lina Zgaga, Åsa Johannson, Irma Redžić, Olga Gornik, Tatijana Zemunik, Ozren Polašek, Ivana Kolčić, Marina Pehlić, Carolien A.M. Koeleman, Susan Campbell, Sarah H. Wild, Nicholas D. Hastie, Harry Campbell, Ulf Gyllensten, Manfred Wuhrer, James F. Wilson, Caroline Hayward, Igor Rudan, Pauline M. Rudd, Alan F. Wright, and Gordan Lauc. Polymorphisms in b3gat1, slc9a9 and mgat5 are associated with variation within the human plasma n-glycome of 3533 european adults. Human Molecular Genetics, 20(24):5000–5011, September 2011. URL: http://dx.doi.org/10.1093/hmg/ddr414, doi:10.1093/hmg/ddr414. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddr414)

[4. (Górska2016The) Aleksandra Górska, Marta Gruchała-Niedoszytko, Marek Niedoszytko, Agnieszka Maciejewska, Marta Chełmińska, Marcin Skrzypski, Bartosz Wasąg, Małgorzata Kaczkan, Magdalena Lange, Bogusław Nedoszytko, Ryszard Pawłowski, Sylwia Małgorzewicz, and Ewa Jassem. The role of traf4 and b3gat1 gene expression in the food hypersensitivity and insect venom allergy in mastocytosis. Archivum Immunologiae et Therapiae Experimentalis, 64(6):497–503, April 2016. URL: http://dx.doi.org/10.1007/s00005-016-0397-7, doi:10.1007/s00005-016-0397-7. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00005-016-0397-7)